Abstract |
The present study was undertaken to inquest the chemical activation of prolyl hydroxylase-2 for the curtailment of hypoxia-inducible factor-1α and fatty acid synthase. It was well documented that hypoxia-inducible factor-1α and fatty acid synthase were overexpressed in mammary gland carcinomas. After screening a battery of compounds, BBAP-2 was retrieved as a potential prolyl hydroxylase-2 activator and validates its activity using ER + MCF-7 cell line and n-methyl-n-nitrosourea-induced rat in vivo model, respectively. BBAP-2 was palpable for the morphological characteristics of apoptosis along with changes in the mitochondrial intergrity as visualized by acridine orange/ ethidium bromide and JC-1 staining against ER + MCF-7 cells. BBAP-2 also arrest the cell cycle of ER + MCF-7 cells at G2/M phase. Afterward, BBAP-2 has scrutinized against n-methyl-n-nitrosourea-induced mammary gland carcinoma in albino Wistar rats. BBAP-2 restored the morphological architecture when screened through carmine staining, haematoxylin and eosin staining, and scanning electron microscopy. BBAP-2 also delineated the markers of oxidative stress favourably. The immunoblotting and mRNA expression analysis validated that BBAP-2 has a potentialty activate the prolyl hydroxylase-2 with sequential downregulating effect on hypoxia-inducible factor-1α and its downstream checkpoint. BBAP-2 also fostered apoptosis through mitochondrial-mediated death pathway. The present study elaborates the chemical activation of prolyl hydroxylase-2 by which the increased expression of HIF-1α and FASN can be reduced in mammary gland carcinoma.
|
Authors | Uma Devi, Manjari Singh, Subhadeep Roy, Pushpraj S Gupta, Mohd Nazam Ansari, Abdulaziz S Saeedan, Gaurav Kaithwas |
Journal | Cell biochemistry and function
(Cell Biochem Funct)
Vol. 37
Issue 4
Pg. 216-227
(Jun 2019)
ISSN: 1099-0844 [Electronic] England |
PMID | 30950543
(Publication Type: Journal Article)
|
Copyright | © 2019 John Wiley & Sons, Ltd. |
Chemical References |
- Antineoplastic Agents
- Benzopyrans
- HIF1A protein, human
- Hypoxia-Inducible Factor 1, alpha Subunit
- Receptors, Estrogen
- EGLN1 protein, human
- Hypoxia-Inducible Factor-Proline Dioxygenases
- FASN protein, human
- Fatty Acid Synthase, Type I
|
Topics |
- Animals
- Antineoplastic Agents
(chemistry, pharmacology)
- Apoptosis
(drug effects)
- Benzopyrans
(chemistry, pharmacology)
- Breast Neoplasms
(drug therapy, metabolism, pathology)
- Cell Proliferation
(drug effects)
- Down-Regulation
(drug effects)
- Drug Screening Assays, Antitumor
- Enzyme Activation
(drug effects)
- Fatty Acid Synthase, Type I
(metabolism)
- Female
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit
(metabolism)
- Hypoxia-Inducible Factor-Proline Dioxygenases
(metabolism)
- MCF-7 Cells
- Mammary Neoplasms, Experimental
(drug therapy, metabolism, pathology)
- Mitochondria
(drug effects, metabolism, pathology)
- Rats
- Rats, Wistar
- Receptors, Estrogen
(metabolism)
|